Fibroblast growth factor 8 (Fgf8) is a secreted growth factor involved in the initiation, outgrowth and patterning of vertebrate limbs (Genes Dev. 12 (1998) 1571. In this paper, we present a new site of expression of Fgf8 in the chick limb. Fgf8 transcripts are localised close to the muscle fibres, at the same level as the tendon-associated molecules, tenascin and scleraxis. Fgf8 is expressed in a sub-region of the tendons during limb development; its location being restricted to the area near the muscle. In addition, the restricted Fgf8 expression in the tendons allowed us to observe that the myogenic determination factor (MyoD) is not detected at the myotendinous junction. q
Results and discussion
Experiments using the chick/quail marker system have shown that the limb musculature is of double mesodermal origin. Tendons originate from the lateral mesoderm while the skeletal muscles are derived from the somites (Chevallier et al., 1977; Christ et al., 1977) . Surgical manipulations, in the chick, have highlighted the importance of the interactions between tendons and muscles during limb development (Chevallier et al., 1978; Kieny and Chevallier, 1979; Brand et al., 1985; Kardon, 1998) . However, very little is known about the molecular events driving tendon formation. A complex scaffolding of extracellular matrix components such as collagen type I, IV, tenascin and elastin has been observed during the tendon development in the chick limbs (Hurle et al., 1989 (Hurle et al., , 1990 Ros et al., 1995; Kardon, 1998) . The tyrosine kinase receptor, Eph-A4 (ephrin receptor A4), is expressed in the bodies of the distal limb tendons (Patel et al., 1996; D'Souza and Patel, 1999) . Transcription factors have also been described in the distal tendons during limb development in the chick and mouse, such as Six 1 and 2 (Oliver et al., 1995) , Eya 1 and 2 (Xu et al., 1997) and scleraxis (Cserjesi et al., 1995; Tabin et al., 2000) . However, the function of these molecules during the tendon development remains unclear.
The expression of fibroblast growth factor 8 (Fgf8) in the wing mesenchyme is first detected at E5 by in situ hybridisation to whole mount embryos (Fig. 1B) and to sections (data not shown). The mesenchymal Fgf8 expression pattern spreads from proximal to more distal regions during wing development (Fig. 1A-G) , such that by E10, the Fgf8 transcripts are detected in the digits (data not shown). This corresponds to the proximal-distal sequence of the tendon attachment to muscle and cartilage during the chick limb development that has been described previously (Kardon, 1998) . By comparing the appearance of Fgf8 expression in the forearm of the wing (E8) and the timing of the tendon attachment in the shank of the leg (Kardon, 1998) , we presume that Fgf8 is expressed once the tendons have already formed their attachment. Limb mesenchymal expression of the tendon-associated molecules, tenascin (Kardon, 1998) and scleraxis (data not shown) can be detected at least 1 day before Fgf8. However, it is not yet clear whether this earlier expression is in the presumptive tendon regions. At E8, the overall Fgf8 expression pattern matches the tendon network in formation (Fig. 1D,E) and appears very similar to that of scleraxis (Fig. 1F,G) , in the forearm region. At that stage, faint Fgf8 staining can be detected in the distal tendons at the digit level (Fig. 1D,E) , whereas scleraxis is strongly expressed in these structures (Fig. 1F,G) . The analysis of Fgf8 expression on transverse (Fig. 1H) and longitudinal ( Fig. 1J) sections from E9 and E10 wings shows that the Fgf8 transcripts can be detected next to all the muscles of the forearm, indicating that Fgf8 is expressed in all the tendons. Differentiated muscle cells were detected using a monoclonal antibody against myosin heavy chain, MF20. Comparison of Fgf8 and scleraxis expression in sections of the forearms from E9 and E10 embryos shows that the Fgf8 transcripts (Fig. 1H,I ) are more restrictively expressed than those of scleraxis (Fig. 1J,K) and that the Fgf8 transcripts are always associated with the parts of the tendon nearest to the muscle extremities (Fig. 1H,I ) while the scleraxis is detected throughout the tendon bodies, running from the muscle to the cartilage (Fig. 1J,K) .
A comparison of MyoD and Fgf8 expression patterns by in situ hybridisation on consecutive transverse sections of the forearm from E8.5 embryos show that, in the tendon areas where the Fgf8 transcripts are present ( Fig. 2A,B) , the MyoD transcripts (Fig. 2C,D) are not detected in the muscle fibres. In situ hybridisation to longitudinal sections along the wing muscles from E10 embryos confirms the absence of MyoD transcripts (blue) at the extremities of the differentiated muscle fibres (brown) revealed by the MF20 antibody (Fig. 2E,F, arrowed) . The adjacent longitudinal sections hybridised with Fgf8 (Fig. 2G,H) or incubated with the M1B4 antibody against tenascin ( Fig. 2I,J ; Hurle et al., 1990) show the colocation of the tendon-associated molecules outside the differentiated muscle fibres. This shows that the MyoD gene is not expressed at the myotendinous junctions.
In conclusion, this expression pattern identifies Fgf8 as a new molecular marker of tendons in the chick limb. In addition, this restricted Fgf8 expression in tendons allow us to demonstrate that the myogenic factor MyoD is not detected at the myotendinous junction.
Material and methods
Chick embryos were processed for in situ hybridisation to whole mounts and sections as described previously by Edom-Vovard et al. (2001) . Probes were prepared from coding regions of MyoD (Edom-Vovard et al., 2001) , Fgf8 (Martin, 1998) and scleraxis (Cserjesi et al., 1995) genes and transcribed in the presence of digoxigenin coupled to uridine. The digoxigenin-labelled probe was revealed by immunohistochemistry using NBT/BCIP (nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indodyl phosphate).
Differentiated muscle cells were detected in sections using the monoclonal antibody against sarcomeric myosin heavy chain, MF20 (Developmental Hybridoma Bank) and a horseradish peroxidase (HRP)-conjugated secondary antibody and diaminobenzidine (DAB) as a substrate. The tenascin was detected using the monoclonal antibody, M1B4 (Developmental Hybridoma Bank).
